Nation & World

<< Previous   of   Next >>   ADVERTISEMENT   CONTACT THE HERALD Do you have a news tip? newstips@heraldnet.com | 425.339.3400   Published: Monday, June 1, 2009 Fourth way to fight cancer unveiled A so-called cancer vaccine spurs the patient's immune system to attack the disease. Associated Press ORLANDO, Fla. -- First there was surgery, then chemotherapy and radiation. Now, doctors have overcome 30 years of false starts and found success with a fourth way to fight cancer: using the body's natural defender, the immune system. The approach is called a cancer vaccine, although it treats the disease rather than prevents it. One such vaccine kept a common form of lymphoma from worsening for more than a year, researchers said at a cancer conference Sunday. That's huge in this field, where progress is glacial and success with a new treatment is often measured in weeks or even days. Experimental vaccines against three other cancers -- prostate, the deadly skin disease melanoma and an often fatal childhood tumor called neuroblastoma -- also gave positive results in late-stage testing in recent weeks, after decades of struggles in the lab. "I don't know what we did differently to make the breakthrough," said Dr. Len Lichtenfeld of the American Cancer Society. Instead of a single "a-ha!" moment, there have been many "ah, so" discoveries about the immune system that now seem to be paying off, said Dr. John Niederhuber, director of the National Cancer Institute. It's way too soon to declare victory. No one knows how long the benefits will last, whether people will need "boosters" to keep their disease in check, or whether vaccines will ever be a cure. Many vaccines must be custom-made for each patient. How practical will that be, and what will it cost? Those are all good questions -- but there are no answers yet, said Dr. Richard Schilsky, a University of Chicago cancer specialist who is president of the American Society of Clinical Oncology. A big problem has been getting the immune system to "see" cancer as a threat, said Dr. Patrick Hwu, melanoma chief at the University of Texas M.D. Anderson Cancer Center. Viruses like the flu or polio are easily spotted by the immune system because they look different from human cells. "But cancer comes from our own cells. And so it's more like guerrilla warfare -- the immune system has trouble distinguishing the normal cells from the cancer cells," he said. To help it do that, many cancer vaccines take a substance from a cancer cell's surface and attach it to something the immune system already recognizes as foreign -- in the lymphoma vaccine's case, a shellfish protein. "It's a mimic to what you're trying to kill, a training device to train the immune system to kill something," Hwu explained. To make the attack as strong as possible, doctors add a substance to put the immune system on high alert. READER COMMENTS Be the first to comment. You must be a registered user and verify your e-mail address to post comments to blogs or articles on HeraldNet. To register, click here. To read other terms and conditions, click here. Log out

1. Early morning gunfire wounds 2 in Everett 2. Father guilty of manslaughter in girl's death 3. ZZ Top fans get Everett buzzing 4. Crash devastating for toddler 5. Snohomish County budget passes, with a caveat 6. Fall 2009 Wesco All-League Teams 7. Laundry fire sparks concerns over smoke detectors 8. Two people injured in Highway 9 collision 9. Northrop: Boeing's 767 ‘no longer commercially viable' 10. Lynnwood police seek hit-and-run driver 2 - Top 10 Stories Most Talked about 3 - Top 10 Stories Most Emailed

• Holiday Lightings & Santa Sightings • Ruling in the pool • Archbishop Murphy takes title • A season of performing arts • Budget numbers have official fuming • Wildcats move on to 2A semifinals • Holiday Bazaars & Fairs Calendar • Edmonds’ Westgate Chapel serves up hospitality for holiday • Mavericks fall • Boeing will build, flight test and deliver 787s in South Carolina to spe ... • Snohomish County EDC promoting job growth in key industry clusters • $4 million grant to advance brain tumor research has Everett links • Providence medical center construction tops off its 12-story steel frame ... • Tulalip affordable housing project to be financed by KeyBank, Raymond Ja ... • Arlington's Lak of Ink has a growing following for Luke Kooyman's creati ... • Bank of the Northwest formed • Cascade Bank earns $1.6 million